Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Celltrion Healthcare Co., Ltd.

http://www.celltrionhealthcare.com

Latest From Celltrion Healthcare Co., Ltd.

Celltrion Juggles Biosimilar Market Share As It Shifts To Direct Marketing

Celltrion Healthcare was ultimately able to increase its revenue by 16.7%, with stronger growth expected in H2.

Sales & Earnings Biosimilars

AstraZeneca’s Evusheld Wins EU Marketing Nod For Preventing COVID-19

The European Commission is expected to make a “rapid decision” on the European Medicines Agency’s recommendation today that Evusheld should be approved.

Europe Approvals

Celltrion Celebrates Brazilian Tender Win For Infliximab

Celltrion’s Remsima infliximab biosimilar has won a Brazilian federal tender as well as several individual state bids, following earlier awards for the Korean firm’s Truxima (rituximab) and Herzuma (trastuzumab) biosimilars.

Biosimilars Brazil

Seventeen And Counting – Bumper Crop Of New EU Filings

Orphan drugs and COVID-19 products are among the latest filings under review by the European Medicines Agency for potential pan-EU approval.

Europe Drug Review
See All

Company Information

UsernamePublicRestriction

Register